Background: Canine atopic dermatitis (CAD) is a chronic dermatological disease partly due to dysregulation of the immune system. Inappropriate activation of CD4+ lymphocytes could favour and promote the allergic response. An inadequate activation system of regulatory T cells (Tregs) is suspected to be a key immunological feature of the allergic response in atopic dogs. Hypothesis/Objectives: To evaluate the difference in the CD4/CD8 lymphocyte ratio and the percentage of Tregs in healthy dogs, in a breed predisposed to CAD, and in dogs affected by CAD before and during therapy with ciclosporin (CsA). Additionally to assess the improvement in pruritus and skin lesions during therapy with CsA, and to compare this with CD4/CD8/Treg values. Animals: Ten atopic dogs of different breed, sex and age, ten healthy dogs and ten English bulldogs were included. Methods: Peripheral blood from all dogs was tested using flow cytometry to assess the CD4/CD8 ratio and percentage of Tregs. For atopic dogs, sampling was repeated after 30 and 90 days of therapy with CsA. Results: The CD4/CD8 ratio was not significantly different between the three groups. The Treg percentage was higher, but not statistically significant, in atopic dogs compared with controls. Therapy with CsA led to clinical improvement; it was not associated with statistically significant differences in haematological variables. Conclusion and clinical importance: This study suggests that Tregs may be involved in the pathogenesis of CAD and that ciclosporin therapy does not affect the circulating lymphocyte subpopulations.
Lymphocyte subpopulations and Treg cells in dogs with atopic dermatitis receiving ciclosporin therapy : a prospective study / M. Beccati, V. Martini, S. Comazzi, N. Fanton, L. Cornegliani. - In: VETERINARY DERMATOLOGY. - ISSN 0959-4493. - 27:1(2016 Feb), pp. 17-21.
Lymphocyte subpopulations and Treg cells in dogs with atopic dermatitis receiving ciclosporin therapy : a prospective study
V. MartiniSecondo
;S. Comazzi;L. CorneglianiUltimo
2016
Abstract
Background: Canine atopic dermatitis (CAD) is a chronic dermatological disease partly due to dysregulation of the immune system. Inappropriate activation of CD4+ lymphocytes could favour and promote the allergic response. An inadequate activation system of regulatory T cells (Tregs) is suspected to be a key immunological feature of the allergic response in atopic dogs. Hypothesis/Objectives: To evaluate the difference in the CD4/CD8 lymphocyte ratio and the percentage of Tregs in healthy dogs, in a breed predisposed to CAD, and in dogs affected by CAD before and during therapy with ciclosporin (CsA). Additionally to assess the improvement in pruritus and skin lesions during therapy with CsA, and to compare this with CD4/CD8/Treg values. Animals: Ten atopic dogs of different breed, sex and age, ten healthy dogs and ten English bulldogs were included. Methods: Peripheral blood from all dogs was tested using flow cytometry to assess the CD4/CD8 ratio and percentage of Tregs. For atopic dogs, sampling was repeated after 30 and 90 days of therapy with CsA. Results: The CD4/CD8 ratio was not significantly different between the three groups. The Treg percentage was higher, but not statistically significant, in atopic dogs compared with controls. Therapy with CsA led to clinical improvement; it was not associated with statistically significant differences in haematological variables. Conclusion and clinical importance: This study suggests that Tregs may be involved in the pathogenesis of CAD and that ciclosporin therapy does not affect the circulating lymphocyte subpopulations.File | Dimensione | Formato | |
---|---|---|---|
Beccati_et_al-2016-Veterinary_Dermatology.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
667.93 kB
Formato
Adobe PDF
|
667.93 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Lymphocyte subpopulations and Treg manuscript.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
515.86 kB
Formato
Adobe PDF
|
515.86 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.